Valeant Pharmaceuticals reports second quarter 2014 financial results
Valeant Pharmaceuticals reported 2014 second quarter total revenue of $2.0 billion. an increase of 86% over the prior year, and 2014 second quarter GAAP EPS $0.37; and Cash EPS $1.91, an increase of 43% over the prior year period. July 31, 2014